drugset / Trial / NCT06084507

Food Effects of GST-HG171 Tablets Combined With Ritonavir in Healthy Chinese Participants

NCT06084507

Phase 1 Unknown 18 enrolled Fujian Akeylink Biotechnology Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

A single-center, randomized, open, single-dose, two-cycle, two-sequence, cross-over study was conducted to evaluate the effect of food on the pharmacokinetic characteristics of GST-HG171 in combination with Ritonavir.

Timeline

Start
2023-05-04
Primary completion
2023-05-23
Completion
2023-12-27

Drugs

EvaluationDrugModalityDoseRoute
Subject GST-HG171 Small molecule 300 mg Oral
Background Ritonavir Other / unclassified 100 mg Oral

Indications